An unexpected Streptococcus pneumoniae strain.

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Pharmacology

Background:

• Streptococcus pneumoniae is a leading cause of bacterial meningitis.
• Italy typically reports low prevalence of multidrug-resistant (MDR) S. pneumoniae strains.
• Prompt identification and appropriate treatment are crucial for managing pneumococcal meningitis.

Observation:

• An unexpected case of bacterial meningitis caused by an MDR S. pneumoniae strain occurred in Italy.
• Initial treatment with ceftriaxone and dexamethasone was ineffective due to the strain's resistance.
• The patient presented with risk factors including immunosuppression and prior antibiotic therapy.

Findings:

• A second-line treatment regimen including linezolid and levofloxacin was initiated based on susceptibility and pharmacokinetic data.
• The patient showed dramatic clinical improvement following the administration of the new antibiotic regimen.
• Detailed patient history revealed risk factors associated with MDR S. pneumoniae.

Implications:

• This case underscores the emerging threat of MDR S. pneumoniae in regions with previously low prevalence.
• It emphasizes the need for careful consideration of patient risk factors when selecting antibiotic therapy for severe pneumococcal infections.
• Clinicians should maintain a high index of suspicion for MDR strains and adjust treatment strategies accordingly.